References
- BrownMBMartinGPJonesSAAkomeahFKDermal and transdermal drug delivery systems: current and future prospectsDrug Deliv200613317518716556569
- FlatzLConradCRole of T-cell-mediated inflammation in psoriasis: pathogenesis and targeted therapyPsoriasis Target Ther20133110
- DanielsenKOlsenAOWilsgaardTFurbergASIs the prevalence of psoriasis increasing? A 30–year follow-up of a population–based cohortBr J Dermatol201316861303131023374051
- MichalekIMLoringBJohnSMA systematic review of worldwide epidemiology of psoriasisJ Eur Acad Dermatol Venereol201731220521227573025
- NickoloffBJNestleFORecent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunitiesJ Clin Invest2004113121664167515199399
- LowesMABowcockAMKruegerJGPathogenesis and therapy of psoriasisNature2007445713086687317314973
- PradhanMSinghDSinghMRNovel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approachesJ Control Release2013170338039523770117
- HashizumeHItoTYagiHEfficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgarisJ Dermatol200734743043417584318
- ClarkRAGone but not forgotten: lesional memory in psoriatic skinJ Invest Dermatol2011131228328521228808
- AzfarRSGelfandJMPsoriasis and metabolic disease: epidemiology and pathophysiologyCurr Opin Rheumatol200820441642218525354
- MichaRImamuraFWyler von BallmoosMSystematic review and meta-analysis of methotrexate use and risk of cardiovascular diseaseAm J Cardiol201110891362137021855836
- HeydendaelVMSpulsPIOpmeerBCMethotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasisN Engl J Med2003349765866512917302
- LebwohlMTingPKooJPsoriasis treatment: traditional therapyAnn Rheum Dis200564Suppl 2ii83ii8615708945
- SureshPKSinghPSarafSNovel topical drug carriers as a tool for treatment of psoriasis: progress and advancesAfr J Pharm Pharmacol201375138147
- RichardEGHönigsmannHPhototherapy, psoriasis, and the age of biologicsPhotodermatol Photoimmunol Photomed20143013724313462
- KofoedKSkovLZachariaeCNew drugs and treatment targets in psoriasisActa Derm Venereol201595213313925111317
- AndrewsSNJeongEPrausnitzMRTransdermal delivery of molecules is limited by full epidermis, not just stratum corneumPharm Res20133041099110923196771
- SuYHFangJYDrug delivery and formulations for the topical treatment of psoriasisExpert Opin Drug Deliv20085223524918248321
- NestleFOKaplanDHBarkerJPsoriasisN Engl J Med2009361549650919641206
- RahmanMAkhterSAhmadJAhmadMZBegSAhmadFJNanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapyExpert Opin Drug Deliv201512463565225439967
- MarianecciCDi MarzioLRinaldiFNiosomes from 80s to present: the state of the artAdv Colloid Interface Sci201420518720624369107
- ThakkarMBrijeshSOpportunities and challenges for niosomes as drug delivery systemsCurr Drug Deliv20161381275128927017826
- MoghassemiSHadjizadehANano-niosomes as nanoscale drug delivery systems: an illustrated reviewJ Control Release2014185223624747765
- HamishehkarHRahimpourYKouhsoltaniMNiosomes as a propitious carrier for topical drug deliveryExpert Opin Drug Deliv201310226127123252629
- KumarGPRajeshwarraoPNonionic surfactant vesicular systems for effective drug delivery–an overviewAPSB201114208219
- AroraRJainCPAdvances in niosome as a drug carrier: a reviewAJP2007112939
- PilkingtonTBrogdenRNAcitretin: a review of its pharmacology and therapeutic useDrugs1992434597627
- SurberCLaugierJPGeigerJMBunHDurandAMaibachHIHigh-performance liquid chromatography determination of acitretin in plasma and its application to a pharmacokinetic study in human subjectsPharm Res1992910136513691448441
- CarreteroGRiberaMBelinchónIGuidelines for the use of acitretin in psoriasisActas Dermosifiliogr2013104759861623891453
- KatzHIWaalenJLeachEEAcitretin in psoriasis: an overview of adverse effectsJ Am Acad Dermatol1999413 Pt 2S7S1210459140
- SurberCWilhelmKPBermannDMaibachHIIn vivo skin penetration of acitretin in volunteers using three sampling techniquesPharm Res1993109129112948234165
- DunnLKGaarLRYentzerBAO’NeillJLFeldmanSRAcitretin in dermatology: a reviewJ Drugs Dermatol201110777278221720660
- PastuszkaMKaszubaAAcitretin, a systemic retinoid for the treatment of psoriasis-current state of knowledgePost Dermatol Alergol20114285292
- LoftssonTSigurđardóttirAMÓlafssonJHImproved acitretin delivery through hairless mouse skin by cyclodextrin complexationInt J Pharm19951152255258
- AgrawalYPetkarKCSawantKKDevelopment, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasisInt J Pharm20104011–29310220858539
- DivyaGPanonnummalRGuptaSJayakumarRSabithaMAcitretin and aloe-emodin loaded chitin nanogel for the treatment of psoriasisEur J Pharm Biopharm20161079710927368748
- BaillieAJFlorenceATHumeLRMuirheadGTRogersonAThe preparation and properties of niosomes non-ionic surfactant vesiclesJ Pharm Pharmacol198537128638682868092
- AzeemAAhmadFJKhanZITalegaonkarSNonionic surfactant vesicles as a carrier for transdermal delivery of frusemideJ Dispers Sci Technol2008295723730
- MokhtarMSammourOAHammadMAMegrabNAEffect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomesInt J Pharm20083611–210411118577437
- FangJYHongCTChiuWTWangYYEffect of liposomes and niosomes on skin permeation of enoxacinInt J Pharm20012191–2617211337166
- RuckmaniKJayakarBGhosalSKNonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in vitro releaseDrug Dev Ind Pharm200026221722210697760
- HuCRhodesDGProniosomes: a novel drug carrier preparationInt J Pharm19991851233510425362
- SloanKBBeallHDWeimarWRVillanuevaRThe effect of receptor phase composition on the permeability of hairless mouse skin in diffusion cell experimentsInt J Pharm199173297104
- JacobsenJBuccal iontophoretic delivery of atenolol HCl employing a new in vitro three-chamber permeation cellJ Control Release2001701–2839511166410
- El-KattanAFAsbillCSMichniakBBThe effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systemsInt J Pharm2000198217918910767567
- GurrapuAJukantiRBobbalaSRKanugantiSJeevanaJBImproved oral delivery of valsartan from maltodextrin based proniosome powdersAdv Powder Technol2012235583590
- GoyalGGargTMalikBChauhanGRathGGoyalAKDevelopment and characterization of niosomal gel for topical delivery of benzoyl peroxideDrug Deliv20152281027104224251352
- ManconiMSinicoCValentiDLaiFFaddaAMNiosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoinInt J Pharm20063111–2111916439071
- HiguchiTMechanism of sustained-action mediation. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJ Pharm Sci1963521145114914088963
- KorsmeyerRWGurnyRDoelkerEBuriPPeppasNAMechanisms of solute release from porous hydrophilic polymersInt J Pharm19831512535
- RitgerPLPeppasNAA simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discsJ Control Release1987512336
- MadyFMShakerMAEnhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticlesInt J Nanomedicine2017127405741729066891
- ShakerDSShakerMAHanafyMSCellular uptake, cytotoxicity and in vivo evaluation of Tamoxifen citrate loaded niosomesInt J Pharm20154931–228529426200748
- DraizeJHWoodardGCalveryHOMethods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranesJ Pharmacol Exp Ther1944823377390
- ManosroiAChankhampanCManosroiWManosroiJTransdermal absorption enhancement of papain loaded in elastic niosomes incorporated in gel for scar treatmentEur J Pharm Sci201348347448323266464
- NagleAGoyalAKKesarlaRMurthyRREfficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin modelJ Liposome Res201121213414020557280
- SinghalMKansaraNCassia toraLCreams inhibit psoriasis in mouse tail modelPharm Crop2012316
- LaxmiRJKarthikeyanRSrinivasa BabuPNarendra BabuRVVFormulation and evaluation of antipsoriatic gel using natural excipientsJ Acute Dis201322115121
- VijayalakshmiARavichandiranVVelrajMAnti-Psoriatic activity of smilax china linn. rhizomeIJPER20134718289
- KhuranaSJainNKBediPMNanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in vivo and stability evaluationDrug Dev Ind Pharm20154181368137525151872
- UchegbuIFVyasSPNon-ionic surfactant based vesicles (niosomes) in drug deliveryInt J Pharm19981721–23370
- AgarwalRKatareOPVyasSPPreparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranolInt J Pharm20012281–2435211576767
- DevarajGNParakhSRDevrajRApteSSRaoBRRambhauDRelease studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterolJ Colloid Interface Sci2002251236036516290741
- El-MenshaweSFHusseinAKFormulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin deliveryPharm Dev Technol201318477978621913880
- El-SamaligyMSAfifiNNMahmoudEAIncreasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigationInt J Pharm20063081–214014816356669
- LinganMASathaliAAHKumarMRVGokilaAFormulation and evaluation of topical drug delivery system containing clobetasol propionate niosomesSci Revs Chem Commun201111717
- FathallaDAbdel-MageedAAbdel-HamidFAhmedMIn vitro and in vivo evaluation of niosomal gel containing aceclofenac for sustained drug deliveryIJPSR20141111
- ZakiRMAliAAEl MenshaweSFAbdelBaryAFormulation and in vitro evaluation of diacerein loaded niosomesInt J Pharm Pharm Sci20146Suppl 2515521
- VermaDDVermaSBlumeGFahrAParticle size of liposomes influences dermal delivery of substances into skinInt J Pharm20032581–214115112753761
- GuptaRGuptaMMangalSAgrawalUVyasSPCapsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapyArtif Cells Nanomed Biotechnol201644382583425465045
- LasońESikoraEOgonowskiJInfluence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulationActa Biochim Pol201360477377724432330
- ReddyLHMurthyRSEtoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluationAAPS PharmSciTech200562E158E16616353973
- SarmentoBFerreiraDVeigaFRibeiroACharacterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studiesCarbohydr Polym200666117
- Sezgin-BayindirZYukselNInvestigation of formulation variables and excipient interaction on the production of niosomesAAPS PharmSciTech201213382683522644706
- RahmanSAAbdelmalakNSBadawiAElbayoumyTSabryNEl RamlyAFormulation of tretinoin-loaded topical proniosomes for treatment of acne: in vitro characterization, skin irritation test and comparative clinical studyDrug Deliv201522673173924670094
- JadonPSGajbhiyeVJadonRSGajbhiyeKRGaneshNEnhanced oral bioavailability of griseofulvin via niosomesAAPS PharmSciTech20091041186119219856107
- KumarGKarthikLRaoKVBAntimicrobial activity of latex of calotropis gigantea against pathogenic microorganisms. An in vitro studyPhOL20103155163
- AliMFSalemHFAbdelmohsenHFAttiaSKPreparation and clinical evaluation of nano-transferosomes for treatment of erectile dysfunctionDrug Des Devel Ther2015924312447
- AbdellatifAATawfeekHMTransfersomal nanoparticles for enhanced transdermal delivery of clindamycinAAPS PharmSciTech20161751067107426511937
- WuHLiuZPengJDesign and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug deliveryInt J Pharm20114101–2314021397671
- OgisoTNiinakaNIwakiMMechanism for enhancement effect of lipid disperse system on percutaneous absorptionJ Pharm Sci199685157648926585
- BarryBWNovel mechanisms and devices to enable successful trans-dermal drug deliveryEur J Pharm Sci200114210111411500256
- KilfoyleBESheihetLZhangZLaohooMKohnJMichniak- KohnBBDevelopment of paclitaxel-TyroSpheres for topical skin treatmentJ Control Release20121631182422732474
- BarakatHSDarwishIAEl-KhordaguiLKKhalafallahNMDevelopment of naftifine hydrochloride alcohol-free niosome gelDrug Dev Ind Pharm200935563163718989805
- Abu HashimIIEl-DahanMSYusifRMAbd-ElGawadAHArimaHPotential use of niosomal hydrogel as an ocular delivery system for atenololBiol Pharm Bull201437454155124694602
- PaolinoDCoscoDMuzzalupoRTrapassoEPicciNFrestaMInnovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancerInt J Pharm20083531–223324218191509
- ShaikhKPawarAAphaleSMogheAEffect of vesicular encapsulation on in vitro cytotoxicity of ciclopirox olamineInt J Drug Deliv201242139146
- ZareiMNorouzianDHonarvarBMohammadiMShamabadiHEAkbarzadehAPaclitaxel loaded niosome nanoparticle formulation prepared via reverse phase evaporation method: an in vitro evaluationPak J Biol Sci201316629529824498794
- UnRNBarlasFBYavuzMPhyto-Niosomes: in vitro assessment of the novel nanovesicles containing marigold extractInt J Polym Mater20156417927937
- ZhangYZhangKWuZEvaluation of transdermal salidroside delivery using niosomes via in vitro cellular uptakeInt J Pharm2015478113814625448576
- LeMottePKKeidelSApfelCMCharacterization of synthetic retinoids with selectivity for retinoic acid or retinoid X nuclear receptorsBiochim Biophys Acta1996128922983048600988
- ChandraratnaRARational design of receptor-selective retinoidsJ Am Acad Dermatol1998394 Pt 2S124S1289777789
- DiazBVLenoirMCLadouxAFrelinCDémarchezMMichelSRegulation of vascular endothelial growth factor expression in human keratinocytes by retinoidsJ Biol Chem2000275164265010617662
- PfhalMThe molecular mechanism of retinoid action–retinoids today and tomorrowRetinoid Dermatol19964426
- SauratJHRetinoids and psoriasis: novel issues in retinoid pharmacology and implications for psoriasis treatmentJ Am Acad Dermatol1999413 Pt 2S2S610459139
- ArmstrongJLRuizMBoddyAVRedfernCPFPearsonADJVealGJIncreasing the intracellular availability of all-trans retinoic acid in neuroblastoma cellsBr J Cancer200592469670415714209
- ElderJTAströmAPetterssonURetinoic acid receptors and binding proteins in human skinJ Invest Dermatol1992986 SupplS36S41
- MucidaDParkYKimGReciprocal TH17 and regulatory T-cell differentiation mediated by retinoic acidScience2007317583525626017569825
- WernerBBreschMBrennerFMLimaHCComparative study of histopathological and immunohistochemical findings in skin biopsies from patients with psoriasis before and after treatment with acitretinJ Cutan Pathol200835330231018251745
- NiuXCaoWMaHFengJLiXZhangXAcitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgarisJ Dermatol2012391191692122913391
- GuentherLCTopical tazarotene therapy for psoriasis, acne vulgaris, and photoagingSkin Therapy Lett20027314
- ThielitzAGollnickHTopical retinoids in acne vulgaris: update on efficacy and safetyAm J Clin Dermatol20089636938118973403
- DubeyAPrabhuPKabrawalaHGhateVNiosomal gel of Adapalene: its formulation, physicochemical properties and evaluation for mild-acneAdv Biomed Pharma2015212231
- BarkerJNThe pathophysiology of psoriasisLancet199133887612272301676787
- GudjonssonJEJohnstonADysonMValdimarssonHElderJTMouse models of psoriasisJ Invest Dermatol200712761292130817429444
- PalHCChamcheuJCAdhamiVMTopical application of delphinidin reduces psoriasiform lesions in the flaky skin mouse model by inducing epidermal differentiation and inhibiting inflammationBr J Dermatol2015172235436425533330
- NakagumaHKambaraTYamamotoTRat ultraviolet ray B photodermatitis: an experimental model of psoriasis vulgarisInt J Exp Pathol199576165737734340
- SobolevaAGMezentsevAVBruskinSAGenetically modified animals as model systems of psoriasisMol Biol (Mosk)2014484587599 Russian25842844
- MarianecciCRinaldiFMastriotaMAnti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine modelsJ Control Release20121641172523041542
- AbdelbaryAAAbouGhalyMHDesign and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in vitro evaluation and in vivo skin deposition studyInt J Pharm20154851–223524325773359
- LakshmiPKDeviGSBhaskaranSSacchidanandSNiosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studiesIndian J Dermatol Venereol Leprol200773315716117558046